1. Home
  2. |Insights
  3. |ASBCA's FY15 Report – a Look at the Numbers

ASBCA's FY15 Report – a Look at the Numbers

Client Alert | less than 1 min read | 11.05.15

Last month, the Armed Services Board of Contract Appeals published its FY15 Report of Transactions and Proceedings, which provides statistics regarding the adjudication of appeals between contractors and the Army, Navy, Air Force, Corps of Engineers, DLA, DCMA, CIA, NASA, other Defense agencies, and the Washington Metropolitan Area Transit Authority. This year's report reflects that the appellant prevailed in just over half of the appeals decided in the merits (53%) and indicates that, as usual, the board had a high success rate in resolving matters via ADR, with a 93% resolution in non-binding ADR.


Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...